The functional assays, including CCK-8 assay and Transwell assays, were chosen to investigate the functional role of CERS6-AS1 in gastric cancer, and the dual-luciferase reporter gene assay confirmed the function of gastric cancer and the targeting effect of CERS6-AS1 on miR-567. The gene discussed is CERS6; the disease is gastric cancer.